<DOC>
	<DOC>NCT00468481</DOC>
	<brief_summary>The purpose of this study is to determine whether the study drug is safe and effective</brief_summary>
	<brief_title>Efficacy and Safety Study for an Oral Contraceptive Containing Folate</brief_title>
	<detailed_description>Acronym is used in result section: suspected/diagnosed (susp/diag)</detailed_description>
	<mesh_term>Neural Tube Defects</mesh_term>
	<mesh_term>Spinal Dysraphism</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Drospirenone and ethinyl estradiol combination</mesh_term>
	<criteria>Healthy women between 18 and 40 requesting oral contraception The use of steroidal oral contraceptives, or any drug that could alter Oral Contraception metabolism will be prohibited during the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Healthy women requesting contraception</keyword>
	<keyword>Folic Acid</keyword>
</DOC>